Clinical Trial Update: Vinorelbine in Treating Children With Recurrent or Refractory Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of vinorelbine in children with recurrent or refractory cancers completed; the study evaluated vinorelbine in pediatric brain/CNS tumors,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Central Nervous System Tumor
• Neuroblastoma
• Sarcoma

Drugs mentioned

• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Brain and Central Nervous System Tumors, Neuroblastoma | Phase 2 | Status: COMPLETED